(Q42513586)

English

The protective action of nefiracetam against electrophysiological and metabolic damage in the hippocampus after deprivation of glucose and oxygen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The protective action of nefiracetam against electrophysiological and metabolic damage in the hippocampus after deprivation of glucose and oxygen (English)

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

0 references

electrophysiology

1 reference

based on heuristic

inferred from title

author name string

Aihara H

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Li X

2

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Fujiwara S

3

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Matsumura T

4

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Okumura S

5

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Tozaki H

6

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Kanno T

7

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Ohta K

8

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Nagai K

9

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Nishizaki T

10

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

922

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

158-162

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Effects of nefiracetam on amnesia animal models with neuronal dysfunctions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Adenosine activates the K+ channel and enhances cytosolic Ca2+ release via a P2Y purinoceptor in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

A 'long-term-potentiation-like' facilitation of hippocampal synaptic transmission induced by the nootropic nefiracetam

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Recovery of neuronal activity and high-energy compound level after complete and prolonged brain ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Anticonvulsant actions of nefiracetam on epileptic EL mice and their relation to peripheral-type benzodiazepine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Neuronal nicotinic receptors: functional correlates of ligand binding sites

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Presynaptic nicotinic ACh receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Nefiracetam ameliorates learning deficits in older rabbits and may act via the hippocampus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Mecamylamine- or scopolamine-induced learning impairment: ameliorated by nefiracetam.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-15 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2903165-1

7 January 2021

Identifiers

10.1016/S0006-8993(01)03165-1

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42513586&oldid=2046700925"